Home / India News/ ‘ So far, so great’ says AstraZeneca on leading Covid-19 vaccine
Britain’s AstraZeneca said on Thursday that “excellent information was coming in so far” on its vaccine for Covid-19, currently in large-scale human trials and extensively viewed as the front-runner in the race for a shot versus the coronavirus illness.
” The vaccine advancement is progressing well. We have had good data so far. We require to show the efficacy in the scientific programme, however up until now, so excellent,” president Pascal Soriot said on a media call.
Click here for full Covid-19 coverage
AstraZeneca has actually already reached deals with countries to make more than 2 billion doses of its Covid-19 vaccine, established in partnership with the University of Oxford, and states it could be approved by the end of this year.
The company has had a busy couple of months– it